Edward Baruch
Psychiatry · Mount Laurel, NJNPI 1801096284
Payments from drug & device makers
Across 167 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$572
- Alkermes, Inc.$462
- Otsuka America Pharmaceutical, Inc.$266
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$266
- Johnson & Johnson$168
- AbbVie$135
- plus $787 from 18 others
What the payments were for
- Food & beverage$2,58597%
- Education$723%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$400
- LUCEMYRA$100
- ARISTADA INITIO$100
How this compares
$2,657 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 25 | $62,953 |
| Aripiprazole | 63 | $17,031 |
| Effexor XrVenlafaxine Hcl | 12 | $14,727 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 67 | $10,940 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 17 | $9,946 |
| RisperdalRisperidone | 14 | $3,253 |
| Bupropion XlBupropion Hcl | 47 | $2,037 |
| Vilazodone Hcl | 19 | $1,208 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 19 | $1,045 |
| Alprazolam | 84 | $974 |
| Olanzapine | 30 | $859 |
| Benztropine Mesylate | 32 | $745 |
| Trazodone Hcl | 33 | $705 |
| Duloxetine Hcl | 21 | $686 |
| Quetiapine Fumarate | 12 | $654 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Risperdal | $168 | $66,20639 claims |
| Indivior Inc.Suboxone | $42 | $9,94617 claims |
| Almatica Pharma LLCSertraline Hcl | $81 | $34412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Mount Laurel
- Leon RosenbergCherry Hill$6.4M
- Steven GlassClementon$3.9M
- Judith JosephPaterson$3.8M
- Jeffrey ApterPrinceton$1.7M
- Roberta BallCherry Hill$741K
- Marc CantillonLivingston$524K
- Sanjay VarmaPrinceton$479K
- Manuel SanchezNewark$474K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.